The PET-CT Scanner Device Market focuses on providing services and innovations for scanning, imaging, and the detection of any underlying diseases in the body by using a special kind of dye containing radioactive tracers.

The constant increase in the number of chronic diseases across the world is one of the key factors which is accelerating the growth of the PET-CT Scanner Device Market. The upsurge in the number of cancer diseases is an additional factor which is contributing to the growth of the target company. Moreover, the insufficient availability of the radiopharmaceuticals as well as their limited shelf life is expected to expand the growth of the PET-CT Scanner Device Market Growth.PET-CT Scanner Device Market was valued at US$ 2.58 Billion in 2024 and is projected to grow at a CAGR of 6.70% to reach US$ 4.9 Billion by 2034.

The report “Global PET-CT Scanner Device Market, By Type (Stationary Scanners and Mobile Scanners), By Application (Cardiology, Oncology, and Neurology), By End User (Hospitals, Diagnostic Centers, and Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034”

 Key Highlights:

• In October 2022, GE Healthcare introduced one of its successful products – “Omni Legend”. It is a First-of-its-kind-All-Digital PET/CT which can produce high-resolution images with extraordinary image quality. This advanced system features a new type of digital BGO detector material with a small sized crystal which helps in delivering double the sensitivity of the initial digital scanners, and thereby allowing for faster total scan times as well as impressively small lesion. 
• In December 2020, ‘Ga-PSMA-11’ was approved by the FDA as one of the first ⁶⁸Ga-Labeled radiopharmaceutical for PET imaging of Positive Prostate Cancer (PSMA).  This system has been able to precisely localize and help define the degree of the primary prostate cancer. It has also been able to depict another field which relies on risk stratification and detect the exact stage.

Analyst View:

The key factor driving the growth of the PET-CT Scanner Device Market is the increasing prevalence of chronic diseases. Further, a persistent increase in the cancer rates across the world has been accelerating the growth of the target market. The increase in the demand for safe and effective diagnostic systems is also a factor leading to the target market growth. Regardless, the emergence as well as the progressive development in this field is a huge contribution towards the growth of the PET-CT Scanner Device Market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global PET-CT Scanner Device Market, By Type (Stationary Scanners and Mobile Scanners), By Application (Cardiology, Oncology, and Neurology), By End User (Hospitals, Diagnostic Centers, and Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034”

Key Market Insights from the report:

PET-CT Scanner Device Market was valued at US$ 2.58 Billion in 2024 and is projected to grow at a CAGR of 6.70% to reach US$ 4.9 Billion by 2034. The PET-CT Scanner Device Market is segmented based on Type, Application, End User, and by Region.

• Based on the Type, PET-CT Scanner Device Market is segmented into Stationary Scanners, and Mobile Scanners.
• Based on its Applications, PET-CT Scanner Device Market is segmented into Cardiology, Oncology, and Neurology.
• By End User, PET-CT Scanner Device Market is segmented into Hospitals, Diagnostic Centers, and Research Institutes.
• By Region, the PET-CT Scanner Device Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of PET-CT Scanner Device Market:

The prominent players operating in the Global PET-CT Scanner Device Market include, General Electric Co., Toshiba Corporation, Hitachi, Ltd., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG, PerkinElmer, Inc., Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd, and Mediso Ltd.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com